BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1359494)

  • 1. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.
    Reiss K; Porcu P; Sell C; Pietrzkowski Z; Baserga R
    Oncogene; 1992 Nov; 7(11):2243-8. PubMed ID: 1359494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor.
    Ambrose D; Resnicoff M; Coppola D; Sell C; Miura M; Jameson S; Baserga R; Rubin R
    J Cell Physiol; 1994 Apr; 159(1):92-100. PubMed ID: 8138595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
    Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
    Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF1 autocrine system, enhanced expression of late growth related genes, DNA synthesis, and myocyte nuclear mitotic division in rats.
    Reiss K; Kajstura J; Capasso JM; Marino TA; Anversa P
    Exp Cell Res; 1993 Aug; 207(2):348-60. PubMed ID: 8102103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor-induced expression of messenger RNA for the proliferating cell nuclear antigen requires a functional receptor for the insulin-like growth factor I.
    Miura M; Li SW; Dumenil G; Baserga R
    Cancer Res; 1994 May; 54(9):2472-7. PubMed ID: 7909276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism.
    Reiss K; Ferber A; Travali S; Porcu P; Phillips PD; Baserga R
    Cancer Res; 1991 Nov; 51(21):5997-6000. PubMed ID: 1657376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the myb gene product on expression of the PCNA gene in fibroblasts.
    Travali S; Ferber A; Reiss K; Sell C; Koniecki J; Calabretta B; Baserga R
    Oncogene; 1991 Jun; 6(6):887-94. PubMed ID: 1712444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation.
    Wu J; Zhu JQ; Han KK; Zhu DX
    Oncogene; 1990 Jun; 5(6):873-7. PubMed ID: 2141686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of IGF1, IGF1-receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats.
    Reiss K; Meggs LG; Li P; Olivetti G; Capasso JM; Anversa P
    J Cell Physiol; 1994 Jan; 158(1):160-8. PubMed ID: 7505276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
    Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
    Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
    Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
    J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J; Cusmano G; Introna M
    J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 receptor levels and the proliferation of young and senescent human fibroblasts.
    Sell C; Ptasznik A; Chang CD; Swantek J; Cristofalo VJ; Baserga R
    Biochem Biophys Res Commun; 1993 Jul; 194(1):259-65. PubMed ID: 7687431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias.
    Shiosaka T; Tanaka Y
    Anticancer Res; 1989; 9(5):1249-64. PubMed ID: 2589822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media.
    Bacon TA; Wickstrom E
    Oncogene Res; 1991; 6(1):21-32. PubMed ID: 1997946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation.
    Wang LG; Liu XM; Li ZR; Denstman S; Bloch A
    Cell Growth Differ; 1994 Nov; 5(11):1243-51. PubMed ID: 7848925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
    Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
    Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.